Skip to content
AZBio Logo
  • Members
    • AZBio Member Directory
      • Member Login
    • Join AZBio
    • Support AZBio
    • Save with AZBio Purchasing Power
  • AZBio News
    • Voice of the Patient
    • Resources for Media
      • 3rd Party Content
  • Events
    • 2026 State Bio Friends Reception
    • AZBio Day at The Capitol
    • Arizona Bioscience Week 2026
      • Looking Back at AZBW 2025
      • Looking Back at AZBW 2024
    • AZBio Awards 2026
    • White Hat 2026
  • Advocacy
    • AZBio Legislative Watch List for 2026
    • Request to Speak Instructions
    • AZBio Public Policy Principles
    • Arizona Congressional Delegation
    • 2026 Congressional Calendar
  • Resources
    • AZBioPEERS
    • AZBio PEERS Mentoring Program
    • Cost Saving Programs
    • Core Facilities
    • Arizona Life Science Infrastructure
    • Clinical Trials in Arizona
    • AZBio Career Center
    • Arizona BioMap
  • About AZBio
    • What We Do
    • AZBio Board of Directors
    • AZBio Staff
    • Arizona Bioindustry Fact Sheet
    • AZBio History
  • Menu

Category Archives: AZBio News

A Conversation with Lee Hartwell: ‘This is the era of DNA’

Posted on Wed/23/AprilThu/24/April by AZBio

It’s not every day that you get the chance to sit down face-to-face with a Nobel Laureate. But that’s exactly what happened on Tuesday, April 22, 2014, when about 150 Arizona biotechnology movers and shakers shook it up with Leland “Lee” Hartwell, PhD, at the AZBio Leadership Conversation luncheon at the Phoenix Country Club.Continue reading→

Dr. AJ Milici appointed Flagship Biosciences’ Head of Biology

Posted on Wed/23/AprilWed/23/April by AZBio

Flagship Biosciences announced on April 3, 2014 that Dr. Anthony J. Milici has been appointed Head of Biology. Dr. Milici brings over 30 years of pharmaceutical drug development experience in the areas of neurodegenerative disease, inflammation, and oncology.Continue reading→

21-Year-Old Leaves Hospital with a Kidney Saved by the SynCardia Total Artificial Heart

Posted on Tue/22/AprilTue/22/April by AZBio

“I was completely shocked,” recalls Tiernee Gonzalez of Ohio. “I found out that it wasn’t the end, that I had another chance at life.”Continue reading→

Scientists at the UA Make Critical End-Stage Liver Disease Discovery

Posted on Tue/22/AprilTue/22/April by AZBio

The discovery of an unknown cellular pathway has helped scientists and physicians better understand end-stage liver disease and offers a potential target for new therapeutics.Continue reading→

Ulthera files for $86M IPO

Posted on Mon/21/AprilMon/21/April by AZBio

Ulthera, which sells ultrasound energy systems for the non-invasive lifting of eyebrows and skin around the neck, filed on Monday with the SEC to raise up to $86 million in an initial public offering.Continue reading→

Provista Dx announces completion of $6M Series B Financing

Posted on Mon/21/AprilFri/25/April by AZBio

Provista Diagnostics, Inc., (Scottsdale, AZ) a privately held molecular diagnostics company developing and commercializing diagnostic, prognostic and predictive tests for cancers affecting women, today announced completion of its Series B financing.  The $6.0 million Series B financing was fulfilled by the company’s existing investors.Continue reading→

Piper Charitable Trust Announces New President & CEO

Posted on Mon/21/AprilThu/24/April by AZBio

The Board of Trustees of Virginia G. Piper Charitable Trust announced today that Dr. Susan M. Pepin, nationally recognized medical educator, clinician, and researcher, will become the next president and CEO of Virginia G. Piper Charitable Trust, effective July 28, 2014.Continue reading→

Amgen Granted FDA Fast Track Designation for Investigational Ivabradine for Chronic Heart Failure

Posted on Sat/19/AprilSat/19/April by AZBio
Amgen Statement on FDA Fast Track Designation for Investigational Ivabradine for Chronic Heart FailureContinue reading→

Nazneen Aziz Joins Phoenix Children’s as Senior Vice President of Research Affairs

Posted on Sat/19/AprilSat/19/April by AZBio

Nazneen Aziz, PhD, has joined Phoenix Children’s Hospital as Senior Vice President of Research and Chief Research Officer.Continue reading→

Pentagon-backed Keim lab research may open pathways to precision medicine

Posted on Fri/18/AprilFri/18/April by AZBio

Research motivated to blunt the sinister potential of a deadly infectious disease may hold the promise of life-saving treatments at the edge of a transformation in medical care.Continue reading→

Post navigation

« Previous 1 … 318 319 320 321 322 323 324 325 326 327 328 … 415 Next »

Blog Categories

Upcoming Events

  • AZBioPEERS: The Buzz at JPM 2026
            Jan 27, 2026 -
  • LSWC Best Workforce Strategies Roundtable: Building the Life Sciences Workforce of the Future
            Jan 30, 2026 -
  • OBBB - New Rules for Charitable Giving
            Feb 3, 2026 -
  • AZBio Day at The Capitol
            Feb 18, 2026 - Phoenix
  • 2026 Flinn Bio Capital Conference
            Mar 5, 2026 - Phoenix
  • 2026 Flinn Foundation Bio Capital Conference
            Mar 5, 2026 - Phoenix
  • Rare Skeletal Conditions Advocacy Day at the Arizona Capitol
            Mar 16, 2026 - Phoenix
  • Children's Health Advocacy Day 2026
            Mar 23, 2026 - Phoenix
  • IdeaFunding 2026
            Mar 26, 2026 - TUCSON
  • Arizona Tech Week - April 6-12
            Apr 6, 2026 -
  • AZAdvances Health Innovation Showcase - AZTECH WEEK
            Apr 7, 2026 - Phoenix
  • World Parkinson Conference - WPC 2026 Phoenix
            May 24, 2026 - Phoenix
  • BIO International Convention
            Jun 22, 2026 - San Diego
  • Arizona Bioscience Week
            Oct 5, 2026 -
  • 2026 AZBio Awards
            Oct 7, 2026 - Phoenix
  • all events

Blog Archive

  • Click the image for the latest news about AZBio Members
  • Click the image to learn more about AZBio Membership
  • Click the image to learn more
  • Click the image to enter the AZBio Career Center 
  • Click the image to learn more
  • Click the image to learn more
  • Click the logo to learn more
  • Click the logo to learn more
  • Patients are why we do what we do. Click the image to listen to their stories.

Disclaimer
Imprint
Cookie Policy (CA)
Privacy Policy (CA)

Copyright 2026 | Arizona Bioindustry Association, Inc.
A SiteOrigin Theme
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}